Ukkunagar Pharmaceuticals Private Limited - Due diligence report

A 360° intelligence report on Ukkunagar Pharmaceuticals Private Limited: trust score, financial health, credit view, compliance, directors, …

2002-04-09 Visakhapatnam, Andhra Pradesh Active Unlisted Active Compliant
Share
UP Ukkunagar Pharmaceuticals Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Ukkunagar Pharmaceuticals Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
94/100
Trust Score
Low Risk

Ukkunagar Pharmaceuticals Private Limited is assessed as Low Risk with a Trust Score of 94/100. Ukkunagar Pharmaceuticals Private Limited is an active private limited indian non-government company incorporated in 2002, operating in the Trading sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Ukkunagar Pharmaceuticals Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
94/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
90/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
60/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
65/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 2 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 60/100 Moderate
  • Liabilities ≈ 38% EBITDA - stretched.
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
RAMA CHANDRA RAO VEMULAPALLI 01234567 Director 01/04/2018 6 yrs Approved
SATYANARAYANA CHAPARALA 01234567 Director 01/04/2018 6 yrs Approved
THIRUPATHI RAO BOMMI 01234567 Director 01/04/2018 6 yrs Approved
SURI BABU BODDU 01234567 Director 01/04/2018 6 yrs Approved
Suribabu Rongali 01234567 Director 01/04/2018 6 yrs Approved
  • 5 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2017)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2017 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 2 transfer(s)

Promoters hold a minority stake - exact percentages are part of the full report.

Key managerial personnel: THIRUPATHI RAO BOMMI (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 65 · Distress 90
Growth signals & trust indicators
Profit expanded 1.42 year-on-year.
Net margin improved to 2.1x.
Operating for 24+ years.
Active GST registration(s).
Distress signals & risk flags
No critical warning flags detected in the available data.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence95/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment79/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view81/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
01 Nov 2025
Director appointed
Suribabu Rongali (Additional Director)
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
31 Mar 2017
Share transfer (FY 2017)
250.00000000 shares to LALITHA
Share transfer (FY 2017)
250.00000000 shares to MURALI KRISHNA
30 Sep 2016
Director ceased
RAMA CHANDRA RAO VEMULAPALLI
Director ceased
SURI BABU BODDU
Director ceased
SURYA SITA RAMA RAJU KAKARLAPUDI
12 Aug 2016
Director appointed
RAMA CHANDRA RAO VEMULAPALLI (Director)
Director appointed
SURI BABU BODDU (Director)
Director ceased
MOHANA RAO SAMANTHULA
Director ceased
NOOKI NAIDU ADARI
Director ceased
SURI BABU RONGALI
Director ceased
THIRUPATHI RAO BOMMI
30 May 2015
Securities allotted
750 Equity Shares - 82,500.00 raised
10

Key Observations

Auto-generated from the data above
Revenue grew 24% over the last 1 financial year(s).
Net profit margin moved from 0.86 to 61%.
Debt-to-equity stands at 38% - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
5 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a minority stake as per the FY 2017 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Ambar Resources Private Limited U51909GJ2013PTC076512 Ahmedabad, Gujarat, India
Anchal Vyapaar Private Limited U51109WB2005PTC102263 Kolkata, West Bengal, India
Chirag Fabrics Pvt Ltd U17119GJ1987PTC010139 Ahmedabad, Gujarat, India
Hariratan Impex Private Limited U51900MH1994PTC083984 Mumbai, Maharashtra, India
Sri Komal Cotton Mills Private Limited U17299WB2003PTC095669 Kolkata, West Bengal, India
Durga Sanitiles Private Limited U52341OR2011PTC014155 Baripada, Orissa, India
Murli Imports Private Limited U51909DL2011PTC215214 New Delhi, Delhi, India
Tarasha Plywood Private Limited U74900WB2015PTC206304 Kolkata, West Bengal, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Ukkunagar Pharmaceuticals Private Limited before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Ukkunagar Pharmaceuticals Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 60/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 65/100, margin trends, ownership structure and peer set for Ukkunagar Pharmaceuticals Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 94/100, distress signals and MSME payment-delay disclosures - know whether Ukkunagar Pharmaceuticals Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Ukkunagar Pharmaceuticals Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Ukkunagar Pharmaceuticals Private Limited an active company?

Ukkunagar Pharmaceuticals Private Limited has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Ukkunagar Pharmaceuticals Private Limited financially healthy?

Ukkunagar Pharmaceuticals Private Limited has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.

Should I do business with Ukkunagar Pharmaceuticals Private Limited?

Its overall Trust Score is 94/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Ukkunagar Pharmaceuticals Private Limited?

Promoters hold a minority stake - exact percentages are in the full report. 5 active director(s) are on record.

Does Ukkunagar Pharmaceuticals Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Ukkunagar Pharmaceuticals Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Ukkunagar Pharmaceuticals Private Limited?

Its Credit Risk Score is 60/100 (Moderate). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.